BioLine Rx Ltd
(STU:YP2)
€
2.7
+0.30 (+12.5%)
Market Cap: 11.74 Mil
Enterprise Value: 8.13 Mil
PE Ratio: 9,999.00
PB Ratio: 0.79
GF Score: 26/100 BioLine Rx Ltd (STU:YP2) Transcripts
- 1